Michael Bell
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
Derzeit hat Michael Bell die Position des Chief Financial Officer bei Guardant Health, Inc. inne. Zuvor war Michael Bell Chief Financial & Chief Accounting Officer bei CareDx, Inc, Chief Financial Officer bei Singulex, Inc, Chief Financial Officer bei Metabiota, Inc, Finance Director bei Chiron Corp, Head-Finance bei Novartis Corp, Chief Financial Officer bei Novartis Vaccines & Diagnostics, Inc, Chief Financial Officer der Novartis Pharma AG, Principal bei Deloitte & Touche LLP und Principal bei Ernst & Young LLP (Missouri). Er erwarb einen Bachelor-Abschluss an der Universität von Leicester.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GUARDANT HEALTH, INC. 0,04 % | 15.06.2026 | 48 452 ( 0,04 % ) | 6 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GUARDANT HEALTH, INC. | Finanzdirektor/CFO | 05.01.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| CAREDX, INC. | Finanzdirektor/CFO | 31.12.2020 |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Finanzdirektor/CFO | 01.03.2017 |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Finanzdirektor/CFO | 01.01.2016 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Finanzdirektor/CFO | 01.01.2012 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Finanzdirektor/CFO | 01.01.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Health Technology |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Commercial Services |
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen